By disabling a dementia-linked protein, a synthetic drug is showing a tantalizing capacity to interfere with the formation of waxy amyloid deposits like those that accumulate in the brains of people with Alzheimer’s disease.
In those people, the protein, serum amyloid P, seems to exacerbate the buildup by linking amyloid molecules into more durable deposits.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.